Cholinesterase InhibitorsAlzheimer's Disease changes the brain in many ways. Research has shown that there is a decrease in the level of acetylcholine, a chemical messenger that assists memory, thought and judgment. Cholinesterase inhibitors were developed to improve the effectiveness of acetylcholine either by increasing the levels in the brain or by strengthening the way nerve cells respond to it. Increased concentrations of acetylcholine in the brain lead to increase communication between nerve cells and may temporarily improve or stabilize the symptoms of Alzheimer's disease. These drugs appear to work best in the early and moderate stages of Alzheimer's Disease. These medications do not work for all patients. Some people will improve, some will not and others will continue to deteriorate. In cases where these drugs appear to be effective, patients and caregivers reported a slowing in symptoms such as memory loss, reduced anxiety, improved mood and restored confidence levels. Once a patient stops taking a drug, their condition will deteriorate over a period of 4 to 6 weeks until they are at the same point as an individual who has not taken the drug. Drug Information:
|
 |
|
|||||||||||||||||||||
